EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune Activation

Shannon E Lynch, Heba M Alsheikh, Patrick N Song, Candace C Parker, Yujun Zhang, Clayton C Yates, Benjamin M Larimer, Suzanne E Lapi, Lalita A Shevde, Anna G Sorace iD

Molecular Imaging and Biology · 2025

DOI: 10.1007/s11307-025-02027-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Imaging and Biology, 2025. Verfasst von Shannon E Lynch und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The University of Alabama at Birmingham, VH G082, 1670 University Blvd, Birmingham, AL, 35233, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for the National Institutes of Health, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Obesity and type 2 diabetes (T2D) influence the tumor microenvironment by altering glucose metabolism, which has been shown to decrease immune cell infiltration and activation. Positron emission tomography (PET) imaging provides a non-invasive method to detect molecular markers of immune populations in the tumor microenvironment and systemic organs. The goal of this study is to utilize advanced molecular imaging to quantify differences in innate and adaptive immune responses in diabetic obese mice systemically and within the tumor microenvironment.

Methods

5–6-week-old female C57BL6/J mice were placed on a high-fat diet (HFD) composed of 60% kcal fat or control low-fat diet with 10% kcal fat. Animals were treated with subsequent low doses of streptozotocin to induce T2D and blood glucose was monitored. Following induction of diabetes, E0771-luc + cells were implanted into the 4th mammary fat pad and allowed to grow to a tumor volume of 100mm 3 . PET imaging was acquired over the course of 5 days with the following tracers: [ 18 F]-FDG PET for glucose metabolism, [ 68 Ga]Ga-RP832c (CD206) PET for M2 macrophages, and [ 68 Ga]Ga-GZP PET for granzyme B, an indicator of effector cell activation, and [ 18 F]-DPA-714 PET for neuroinflammation. Regions of interest were identified for the tumor, brain, kidneys, heart, muscle, brown adipose tissue (BAT), to characterize differences in important organs and tumor tissue. Metrics of standardized uptake value (SUV) were extracted from imaging data including mean, max, peak, and tumor-to-background ratios. Following the final imaging timepoint, tumors were extracted for biological characterization via flow cytometry.

Results

Diabetic obese mice have no difference in tumor glucose metabolism, but have decreased FDG uptake in the brain and BAT compared to controls. Obesity and T2D systemically affect innate and adaptive immune infiltration and activation including significantly increased RP832c and GZP in muscle, heart, brain, and BAT. Hyperglycemic tumors had trending decreases in GZP SUV mean and increased RP832c SUV mean . Flow cytometry shows diabetic obese tumors have a significant increase in CD206 + macrophages and no significant difference in GZB + CD8 + T cells compared to controls.

Conclusion

PET imaging reveals that obesity and T2D alter glucose metabolism and immune activation while suppressing tumor-immune activation in diabetic obese mice both within the tumor microenvironment and systemically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2AnimalsFemaleMice, Inbred C57BLTumor MicroenvironmentMiceFluorodeoxyglucose F18Diet, High-FatGlucoseCell Line, Tumor

Stichwörter der Autor:innen

Breast cancerCD206FDGGranzyme BObesityType 2 diabetes

Substanzen

Fluorodeoxyglucose F18Glucose

Autor:innen und Institutionen

  • Department of Radiology, The University of Alabama at Birmingham, VH G082, 1670 University Blvd, Birmingham, AL, 35233, USA.
  • Department of Biomedical Sciences, The University of Alabama, Birmingham, Birmingham, AL, USA.
  • Department of Pathology, The University of Alabama at Birmingham, WTI 320D, 1824 6th Ave S, Birmingham, AL, 35233, USA.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.
  • O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, USA.

ORCID-Profile: Anna G Sorace

Förderung

  • Foundation for the National Institutes of Health
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Lynch, S. E., Alsheikh, H. M., Song, P. N., Parker, C. C., Zhang, Y., Yates, C. C., Larimer, B. M., Lapi, S. E., Shevde, L. A., & Sorace, A. G. (2025). PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune Activation. Molecular Imaging and Biology. https://doi.org/10.1007/s11307-025-02027-y

Vancouver

Lynch SE, Alsheikh HM, Song PN, Parker CC, Zhang Y, Yates CC, et al. PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune Activation. Molecular Imaging and Biology. 2025. doi:10.1007/s11307-025-02027-y

BibTeX
@article{Lynch2025,
  author = {Lynch, Shannon E and Alsheikh, Heba M and Song, Patrick N and Parker, Candace C and Zhang, Yujun and Yates, Clayton C and Larimer, Benjamin M and Lapi, Suzanne E and Shevde, Lalita A and Sorace, Anna G},
  title = {PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune Activation},
  journal = {Molecular Imaging and Biology},
  year = {2025},
  doi = {10.1007/s11307-025-02027-y}
}
Kostenlos starten →